The Wall Street Reform and Consumer Protection Act of 2009 (H.R. 4173),
just adopted by the House of Representatives (and sent to the Senate as S.3217) includes language --
offered by Rep. Waxman [D - CA]
-- giving more power to the Federal Trade Commission to make general rules for interstate commerce that could be used to restrict truthful
information about dietary supplements, by requiring expensive, "drug company" level clinical trials before vitamin companies could
make claims about their products. ================================================= Help protect our supplies by objecting to this.
-------------------- Suspected Lyme 07 Test neg One band migrating in IgG region unable to identify.Igenex Jan.09IFA titer 1:40 IND IgM neg pos 31 +++ 34 IND 39 IND 41 IND 83-93 + DX:Neuroborreliosis Posts: 5850 | From Kentucky | Registered: Dec 2008
| IP: Logged |